Pharmis India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 19-05-2024
- Paid Up Capital ₹ 0.10 M
as on 19-05-2024
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
About Pharmis India
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dhaval Patel and Abhishek Thakkar serve as directors at the Company.
- CIN/LLPIN
U24100GJ2020PTC119218
- Company No.
119218
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Dec 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pharmis India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhaval Patel  | Director | 17-Dec-2022 | Current |
| Abhishek Thakkar | Director | 30-Dec-2020 | Current |
Financial Performance of Pharmis India.
Enhance accessibility to Pharmis India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Pharmis India?
Unlock access to Pharmis India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Spot Multi Commodities Market LimitedActive 9 years 5 monthsDhaval Patel and Abhishek Thakkar are mutual person
Amero Research & Loyalty Solutions Private LimitedActive 8 years 4 monthsDhaval Patel and Abhishek Thakkar are mutual person
Aramco Greens Private LimitedActive 4 years 11 monthsDhaval Patel and Abhishek Thakkar are mutual person
- Bizfly Airlines Private LimitedActive 1 year 7 months
Dhaval Patel and Abhishek Thakkar are mutual person
- Amero Electronics Private LimitedActive 1 year 7 months
Dhaval Patel and Abhishek Thakkar are mutual person
- Uni Port India Private LimitedActive 1 year 7 months
Dhaval Patel and Abhishek Thakkar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmis India?
Pharmis India has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmis India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmis India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
